SALINAS, Calif.--(BUSINESS WIRE)--Next Pharmaceuticals (NP) announced today the results of a clinical study on Seditol, a natural formulation that promotes a good night’s sleep. Seven hundred and seventy-three people completed the open-label trial which concluded that Seditol provides relaxation, promotes restful sleep and helps reduce fatigue due to lack of sleep with minimal side effects. The LaValle Metabolic Institute in Cincinnati, Ohio conducted the study with Principal Investigator Jim LaValle, R.Ph., N.M.D., C.C.N. The primary objective was to study the efficacy and safety of Seditol while measuring its effects on quality of sleep.
